CoreAge Rx vs MediRX
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MediRX head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make MediRX a bad call — it's best for people comparing injection and oral treatment who confirm the full prescription quote, clinical assignment and written cancellation terms. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | MediRX |
|---|---|---|
| Brief Score | 94/100 (A) | 64/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Injection from $149 Oral tablets from $249; full supply and renewal quote unknown. Medication and delivery advertised included; cancellation notice 72 hours. Full price detailsCompounded semaglutide injection and oral options listed; complete selected-prescription quote unknown; main offer injection from $149, oral tablets from $249 without established full supply period or renewal charge |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Injection from $199 Oral tablets from $279; full supply and renewal quote unknown. Medication and delivery advertised included; cancellation notice 72 hours. Full price detailsCompounded tirzepatide injection and oral options listed; complete selected-prescription quote unknown; main offer injection from $199, oral tablets from $279 without established full supply period or renewal charge |
| Coverage | US only; restrictions by state, confirmed at intake | Terms advertise all 50 states plus DC; clinician licensing, pharmacy eligibility and required live visits still depend on patient location. |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
MediRX: MediRX lists injection and oral options without membership fees, but the full supply price and its overlapping refund cutoffs need confirmation.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.